Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of pre-operative (Pre-op), single-dose ipilimumab (Ipi) andlor cryoablation (Cryo) in women (pts) with early stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Solomon, S. B.; Comstock, C.; Maybody, M.; Sacchini, V.; Durack, J.; Blum, B.; Yuan, J.; Patil, S.; Neville, D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Select neutrophils inhibit breast cancer metastases in patients via chemokine-mediated mechanisms
    Meeting Abstract

    Comen, E. A.; Granot, Z.; Blum, B.; Coker, C.; Shah, R.; Seshan, V.; Norton, L.; Benezra, R.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Chemotherapy-related amenorrhea on adjuvant paclitaxel-trastuzumab (APT trial)
    Meeting Abstract

    Ruddy, K. J.; Tolaney, S. M.; Guo, H.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; Ellis, M. J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Cardiac safety of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as (neo) adjuvant therapy for human epidermal growth factor receptor 2-positive (HER2+) early-stage breast cancer (EBC): Final data from TDM4874g
    Meeting Abstract

    Krop, I. E.; Suter, T. M.; Dirix, L.; Romieu, G.; Zamagni, C.; Citron, M. L.; Campone, M.; Dang, C. T.; Xu, N.; Smitt, M.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Impact of adjuvant trastuzumab (T) with chemotherapy on breast cancer specific and cardiac outcomes in older women with small, node-negative HER2-positive breast cancer
    Meeting Abstract

    Cadoo, K. A.; Morris, P. G.; Patil, S.; Norton, L.; Hudis, C. A.; McArthur, H. L.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Morris, P. G.; Lake, D. E.; D'Andrea, G. M.; Dickler, M. N.; Gilewski, T. A.; Dang, C. T.; McArthur, H. L.; Bromberg, J. F.; Goldfarb, S. B.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
    Meeting Abstract

    Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer
    Meeting Abstract

    Traina, T. A.; O'Shaughnessy, J.; Kelly, C.; Schwartzberg, L.; Gucalp, A.; Peterson, A.; Bhattacharya, S.; Trudeau, M.; Hudis, C. A.; Schmid, P.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A multicenter phase II study of docosahexaenoic acid (DHA) in triple negative breast cancer (TNBC) survivors
    Meeting Abstract

    Gucalp, A.; Morris, P. G.; Zhou, X. K.; Giri, D. D.; Iyengar, N. M.; Heckman-Stoddard, B. M.; Dunn, B.; Garber, J. E.; Crew, K. D.; Hershman, D. L.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Significance of circulating tumor cells in metastatic triple negative breast cancer: Results of an open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 tigatuzumab (TBCRC 019)
    Meeting Abstract

    Paoletti, C.; Li, Y.; Muñiz, M. C.; Kidwell, K. M.; Aung, K.; Thomas, D. G.; Brown, M. E.; Abramson, V.; Irvin, W. J. Jr; Lin, N. U.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save